N-of-1 Clinical Trials: A Scientific Approach to Personalized Medicine for Patients with Rare Retinal Diseases Such as Retinitis Pigmentosa-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

N-of-1 Clinical Trials: A Scientific Approach to Personalized Medicine for Patients with Rare Retinal Diseases Such as Retinitis Pigmentosa

Published:2021-11-01 Issue:9 Volume:37 Page:495-501
ISSN:1080-7683
Container-title:Journal of Ocular Pharmacology and Therapeutics
language:en
Short-container-title:Journal of Ocular Pharmacology and Therapeutics

Author:

Zarbin Marco A.¹,Novack Gary²³

Affiliation:

1. Institute of Ophthalmology and Visual Science, Rutgers-New Jersey Medical School, Rutgers University, Newark, New Jersey, USA.

2. PharmaLogic Development, Inc., San Rafael, California, USA.

3. Department of Ophthalmology & Visual Sciences, School of Medicine, University of California, Davis, Sacramento, California, USA.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmacology,Ophthalmology

Link

https://www.liebertpub.com/doi/pdf/10.1089/jop.2021.0059

Reference37 articles.

1. Partial recovery of visual function in a blind patient after optogenetic therapy

2. What is an adequate and well controlled study?

3. Real world evidence for pharmaceuticals

4. Current Concepts and Emerging Gene Therapies for Inherited Retinal Diseases

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Orphan drug development: Challenges, regulation, and success stories;Journal of Biosciences;2024-02-19

2. Discovery and Potential Utility of a Novel Non-Invasive Ocular Delivery Platform;Pharmaceutics;2023-09-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP